Vogivoc-0.3 Tablets

Vogivoc-0.3 contains Voglibose, an alpha-glucosidase inhibitor that helps manage post-meal blood sugar levels in patients with type 2 diabetes mellitus. By delaying carbohydrate absorption in the intestines, Voglibose aids in controlling blood glucose spikes after meals, contributing to better overall glycemic control.

Benefits:

• Effective postprandial blood sugar control: Reduces sudden spikes in blood glucose after meals.

• Supports overall diabetes management: Helps maintain stable blood sugar levels alongside diet and exercise.

• Improves insulin sensitivity: Assists in better utilization of insulin by the body.

• Low risk of hypoglycemia: Safer profile when used as directed.

• Manufactured under GMP and ISO standards: Ensures quality, safety, and efficacy.

Dosage:

• As prescribed by your healthcare provider.

• Typically taken just before meals to maximize effectiveness.

Why Cardiever?

• Premium quality: Manufactured under strict GMP and ISO guidelines for consistency and safety.

• Trusted brand: Focus on providing effective diabetes care solutions.

• Affordable and accessible: Quality medicines at competitive prices.

• Reliable supply chain: Ensures consistent availability to support ongoing treatment.

• Expert-backed: Developed by experienced pharmaceutical professionals committed to patient well-being.